By allowing ads to appear on this site, you support the local businesses who, in turn, support great journalism.
Mpox has faded in the US. Who deserves the credit?
preview.jpg
FILE - A physician assistant prepares a syringe with the Mpox vaccine for a patient at a vaccination clinic in New York on Friday, Aug. 19, 2022. Mpox is no longer the exploding health crisis that it appeared to be less than six months ago. So who deserves the credit for controlling the U.S. outbreak? It’s an unsettled question, but experts cite a combination of factors.Some commend public health officials. - photo by AP Photo/Mary Altaffer, File
NEW YORK (AP) — Less than six months ago, mpox was an exploding health crisis. What had been an obscure disease from Africa was ripping through European and U.S. gay communities. Precious doses of an unproven vaccine were in short supply.